RO0504985 is an inhibitor of CMGC kinase proteins and has anti-human cytomegalovirus activity
- 1 August 2017
- journal article
- Published by Elsevier in Antiviral Research
- Vol. 144, 21-26
Abstract
No abstract availableKeywords
Funding Information
- St. George's, University of London
- National Institutes of Health (R01 AI019838, R01 AI026077)
This publication has 30 references indexed in Scilit:
- Sites and roles of phosphorylation of the human cytomegalovirus DNA polymerase subunit UL44Virology, 2011
- Reconstruction of the complete human cytomegalovirus genome in a BAC reveals RL13 to be a potent inhibitor of replicationJournal of Clinical Investigation, 2010
- Statistical methods for analysis of high-throughput RNA interference screensNature Methods, 2009
- Nuclear Export of the Human Cytomegalovirus Tegument Protein pp65 Requires Cyclin-Dependent Kinase Activity and the Crm1 ExporterJournal of Virology, 2007
- The IE2 60-Kilodalton and 40-Kilodalton Proteins Are Dispensable for Human Cytomegalovirus Replication but Are Required for Efficient Delayed Early and Late Gene Expression and Production of Infectious VirusJournal of Virology, 2007
- Viral and Cell Cycle–Regulated Kinases in Cytomegalovirus-Induced Pseudomitosis and ReplicationPLOS Pathogens, 2007
- Cyclin-Dependent Kinase Activity Is Required for Efficient Expression and Posttranslational Modification of Human Cytomegalovirus Proteins and for Production of Extracellular ParticlesJournal of Virology, 2006
- Selective Anti-Cytomegalovirus Compounds Discovered by Screening for Inhibitors of Subunit Interactions of the Viral PolymeraseChemistry & Biology, 2006
- Characterization of a Human Cytomegalovirus with Phosphorylation Site Mutations in the Immediate-Early 2 ProteinJournal of Virology, 2002
- GanciclovirDrugs, 1994